At the same time, despite experts’ suggestions to reconsider diabetes management on a case-by-case basis, in view of patient setting and clinical judgment [65,66], no specific recommendations on the initiation and use of GLP1 RAs during the COVID-19 pandemic have been provided to diabetes specialists. The gene discussed is GCG; the disease is diabetes mellitus.